Article Details

BridgeBio Pharma, Inc. (NASDAQ:BBIO) down -23.4% YTD: Any Troubles Ahead?

Retrieved on: 2021-04-24 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

BridgeBio Pharma, Inc. (NASDAQ:BBIO) down -23.4% YTD: Any Troubles Ahead?. View article details on hiswai:

Excerpt

In total, 252 institutions holds shares in the company, led by Kohlberg Kravis Roberts & Co. L.P. As of Dec 30, 2020, the company held over 34.51 ...

Article found on: marketingsentinel.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up